Development and applications of single-cycle infectious influenza A virus (sciIAV)

被引:37
作者
Nogales, Aitor [1 ]
Baker, Steven F. [1 ]
Domm, William [1 ]
Martinez-Sobrido, Luis [1 ]
机构
[1] Univ Rochester, Sch Med & Dent, Dept Microbiol & Immunol, 601 Elmwood Ave, Rochester, NY 14642 USA
关键词
Reporter virus; Viral vectors; Single-cycle virus; Influenza vaccine; Influenza HA-expressing MDCK cells (MDCK-HA); Reverse genetics; RECEPTOR-BINDING; VIRAL-RNA; PANDEMIC INFLUENZA; PACKAGING SIGNALS; HEMAGGLUTINATION ASSAY; SEASONAL INFLUENZA; ANTIGENIC DRIFT; GENE SEGMENTS; CELL-CULTURE; SIALIC-ACID;
D O I
10.1016/j.virusres.2015.07.013
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The diverse host range, high transmissibility, and rapid evolution of influenza A viruses justify the importance of containing pathogenic viruses studied in the laboratory. Other than physically or mechanically changing influenza A virus containment procedures, modifying the virus to only replicate for a single round of infection similarly ensures safety and consequently decreases the level of biosafety containment required to study highly pathogenic members in the virus family. This biological containment is more ideal because it is less apt to computer, machine, or human error. With many necessary proteins that can be deleted, generation of single-cycle infectious influenza A viruses (sciIAV) can be achieved using a variety of approaches. Here, we review the recent burst in scilAV generation and summarize the applications and findings on this important human pathogen using biocontained viral mimics. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:26 / 40
页数:15
相关论文
共 183 条
[21]   Influenza vaccine: The challenge of antigenic drift [J].
Carrat, F. ;
Flahault, A. .
VACCINE, 2007, 25 (39-40) :6852-6862
[22]  
Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P431
[23]   A novel influenza A virus mitochondrial protein that induces cell death [J].
Chen, WS ;
Calvo, PA ;
Malide, D ;
Gibbs, J ;
Schubert, U ;
Bacik, I ;
Basta, S ;
O'Neill, R ;
Schickli, J ;
Palese, P ;
Henklein, P ;
Bennink, JR ;
Yewdell, JW .
NATURE MEDICINE, 2001, 7 (12) :1306-1312
[24]   One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis [J].
Chou, Yi-ying ;
Vafabakhsh, Reza ;
Doganay, Sultan ;
Gao, Qinshan ;
Ha, Taekjip ;
Palese, Peter .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (23) :9101-9106
[25]   Influenza A Virus Utilizes Suboptimal Splicing to Coordinate the Timing of Infection [J].
Chua, Mark A. ;
Schmid, Sonja ;
Perez, Jasmine T. ;
Langlois, Ryan A. ;
tenOever, Benjamin R. .
CELL REPORTS, 2013, 3 (01) :23-29
[26]   Development of a Mouse-Adapted Live Attenuated Influenza Virus That Permits In Vivo Analysis of Enhancements to the Safety of Live Attenuated Influenza Virus Vaccine [J].
Cox, Andrew ;
Baker, Steven F. ;
Nogales, Aitor ;
Martinez-Sobrido, Luis ;
Dewhurst, Stephen .
JOURNAL OF VIROLOGY, 2015, 89 (06) :3421-3426
[27]  
de Jong J C, 2003, Dev Biol (Basel), V115, P63
[28]   Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection [J].
de Jong, MD ;
Thanh, TT ;
Khanh, TH ;
Hien, VM ;
Smith, GJD ;
Chau, NV ;
Cam, BV ;
Qui, PT ;
Ha, DQ ;
Guan, Y ;
Peiris, JSM ;
Hien, TT ;
Farrar, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2667-2672
[29]   Efficacy of High-Dose versus Standard-Dose Influenza Vaccine in Older Adults [J].
DiazGranados, Carlos A. ;
Dunning, Andrew J. ;
Kimmel, Murray ;
Kirby, Daniel ;
Treanor, John ;
Collins, Avi ;
Pollak, Richard ;
Christoff, Janet ;
Earl, John ;
Landolfi, Victoria ;
Martin, Earl ;
Gurunathan, Sanjay ;
Nathan, Richard ;
Greenberg, David P. ;
Tornieporth, Nadia G. ;
Decker, Michael D. ;
Talbot, H. Keipp .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (07) :635-645
[30]   Replication-defective viruses as vaccines and vaccine vectors [J].
Dudek, T ;
Knipe, DM .
VIROLOGY, 2006, 344 (01) :230-239